Evidence map›Paper›PMID 26661098›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2016

Differential role of afferent and efferent renal nerves in the maintenance of early- and late-phase Dahl S hypertension.

Jason D Foss, Gregory D Fink, John W Osborn

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Renal interoception in health and disease.Autonomic neuroscience : basic & clinical · 2024
    Review
  7. Neuroimmune interplay in kidney health and disease: Role of renal nerves.Autonomic neuroscience : basic & clinical · 2023
    Review
  8. Article
  9. Article
  10. Review
  11. Circadian Control of Sodium and Blood Pressure Regulation.American journal of hypertension · 2021
    Review
  12. Renal denervation based on experimental rationale.Hypertension research : official journal of the Japanese Society of Hypertension · 2021
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Renal nerves and leukocyte infiltration in the kidney during salt-sensitive hypertension.American journal of physiology. Regulatory, integrative and comparative physiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jason D FossUniversity of Minnesota, Department of Integrative Biology and Physiology, Minneapolis, Minnesota; and.
Gregory D FinkMichigan State University, Department of Pharmacology and Toxicology, East Lansing, Michigan.
John W OsbornUniversity of Minnesota, Department of Integrative Biology and Physiology, Minneapolis, Minnesota; and osbor003@umn.edu.
University of Minnesota · USMichigan State University · US

Funding

Targeted Sympathetic Ablation for Treatment of HypertensionR01HL116476 · NHLBI · UNIVERSITY OF MINNESOTA · PI OSBORN, JOHN W · 2014 to 2022
$3.9M
NHLBI NIH HHS HL-116476-01NHLBI NIH HHS R01 HL116476
6 · The paper itself

Abstract

Clinical data suggest that renal denervation (RDNX) may be an effective treatment for human hypertension; however, it is unclear whether this therapeutic effect is due to ablation of afferent or efferent renal nerves. We have previously shown that RDNX lowers arterial pressure in hypertensive Dahl salt-sensitive (S) rats to a similar degree observed in clinical trials. In addition, we have recently developed a method for selective ablation of afferent renal nerves (renal-CAP). In the present study, we tested the hypothesis that the antihypertensive effect of RDNX in the Dahl S rat is due to ablation of afferent renal nerves by comparing the effect of complete RDNX to renal-CAP during two phases of hypertension in the Dahl S rat. In the early phase, rats underwent treatment after 3 wk of high-NaCl feeding when mean arterial pressure (MAP) was ∼ 140 mmHg. In the late phase, rats underwent treatment after 9 wk of high NaCl feeding, when MAP was ∼ 170 mmHg. RDNX reduced MAP ∼ 10 mmHg compared with sham surgery in both the early and late phase, whereas renal-CAP had no antihypertensive effect. These results suggest that, in the Dahl S rat, the antihypertensive effect of RDNX is not dependent on pretreatment arterial pressure, nor is it due to ablation of afferent renal nerves.

Indexed as

Arterial PressureAfferent PathwaysAnimalsAutonomic DenervationDisease Models, AnimalEfferent PathwaysHypertensionKidneyMaleRats, Inbred DahlSodium Chloride, DietaryTime FactorsSodium Chloride, Dietaryafferent renal nervesDahl salt-sensitive ratefferent renal nervesrenal denervation

Identifiers

PMID26661098
PMCPMC4796749
OpenAlexW2258410900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.